Thu, May 13, 2021
Wed, May 12, 2021
Tue, May 11, 2021

David Lebowitz Maintained (SNDX) at Hold with Decreased Target to $20 on, May 12th, 2021

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Decreased Target from $25 to $20 on, May 12th, 2021.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30